Firm gets FDA approval for SPECT/CT imaging system

03/26/2009 | (free registration)

The FDA has given 510(k) clearance to Digirad to market its Cardius X-ACT imaging system. The cardiac SPECT/CT device is capable of low-dose VCT attenuation correction to limit image artifacts caused by overlying tissues. It features a 24-inch-wide detector array and triple-head solid-state digital detectors.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI